MELODY PAIRO: Open Payments
NPI 1528048824 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 28 payments from 15 companies in 2025. Trend: 2023 $407 · 2024 $1,007 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $127 |
| ABBVIE INC. | 3 | $67 |
| SANOFI-AVENTIS U.S. LLC | 1 | $48 |
| Dexcom, Inc. | 2 | $47 |
| Inspire Medical Systems, Inc. | 1 | $45 |
| Lilly USA, LLC | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
Products named: Ozempic, TZIELD, Dexcom G6 Transmitter, INSPIRE, MOUNJARO, Wegovy, CAPLYTA, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
